Tenofovir Disoproxil Succinate

琥珀酸替诺福韦二吡呋酯

Report date: 2022/12/07 18:09:11
NME

Base Information

Drug NameTenofovir Disoproxil Succinate
Drug Alias Name琥珀酸替诺福韦琥珀酸替诺福韦酯琥珀酸泰诺福韦酯
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A